Plasma Leptin, hTERT Gene Expression, and Anthropometric Measures in Obese and Non-Obese Women with Breast Cancer

被引:18
作者
Rahmati-Yamchi, Mohammad [1 ]
Zarghami, Nosratallah [1 ,2 ,3 ]
Rahbani, Mohammad [1 ]
Montazeri, Ali [1 ]
机构
[1] Tabriz Univ Med Sci, Fac Med, Dept Clin Biochem, Tabriz, Iran
[2] Tabriz Univ Med Sci, Endocrine Res Ctr, Tabriz, Iran
[3] Canc Res Network, Tehran, Iran
关键词
breast cancer; obesity; adipokienes;
D O I
10.4137/BCBCR.S6734
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Expression of human telomerase reverse transcriptase (hTERT) occurs in most cancers but its relation with obesity is unclear. This study explores the association between leptin levels and anthropometric indices with hTERT mRNA levels in breast cancer patients of different obesity grades. Materials and methods: In this case-control study, 65 breast cancer patients participated. Expression of tissues hTERT mRNA was carried out by real-time reverse transcription polymerase chain reaction. Leptin concentrations were measured by enzyme-linked immunoassay. Results: Twelve patients (18.46%) were hTERT negative and 53(81.54%) were positive. hTERT mRNA levels were associated with BMI but not with waist circumference (WC) (r = 0.219, P = 0.22) and waist to hip ratio (WHR) (r = 0.212, P = 0.237). Leptin level and hTERT mRNA levels (r = 0.484, P = 0.008) were correlated as well as BMI and hTERT expression. Conclusions: This study has shown a correlation between leptin levels and hTERT expression. These findings may clarify the role of leptin in breast carcinogenesis, and hence obesity could be responsible for increased incidences in breast cancer as well as its progression via enhanced production of leptin.
引用
收藏
页码:27 / 35
页数:9
相关论文
共 36 条
[1]   Body mass index as a prognostic feature in operable breast cancer:: the International Breast Cancer Study Group experience [J].
Berclaz, G ;
Li, S ;
Price, KN ;
Coates, AS ;
Castiglione-Gertsch, M ;
Rudenstam, CM ;
Holmberg, SB ;
Lindtner, J ;
Erzen, D ;
Collins, J ;
Snyder, R ;
Thürlimann, B ;
Fey, MF ;
Mendiola, C ;
Werner, ID ;
Simoncini, E ;
Crivellari, D ;
Gelber, RD ;
Goldhirsch, A ;
International Breast Cancer Study Grp .
ANNALS OF ONCOLOGY, 2004, 15 (06) :875-884
[2]   The changing global patterns of female breast cancer incidence and mortality [J].
Bray, F ;
McCarron, P ;
Parkin, DM .
BREAST CANCER RESEARCH, 2004, 6 (06) :229-239
[3]   Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].
Calle, EE ;
Rodriguez, C ;
Walker-Thurmond, K ;
Thun, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638
[4]  
Cleary MP, 1997, P SOC EXP BIOL MED, V216, P28, DOI 10.3181/00379727-216-44153B
[5]   The hTERTα splice variant is a dominant negative inhibitor of telomerase activity [J].
Colgin, LM ;
Wilkinson, C ;
Englezou, A ;
Kilian, A ;
Robinson, MO ;
Reddel, RR .
NEOPLASIA, 2000, 2 (05) :426-432
[6]   Human mammary cancer progression model recapitulates methylation events associated with breast premalignancy [J].
Dumont, Nancy ;
Crawford, Yongping G. ;
Sigaroudinia, Mahvash ;
Nagrani, Shefali S. ;
Wilson, Matthew B. ;
Buehring, Gertrude C. ;
Turashvili, Gulisa ;
Aparicio, Samuel ;
Gauthier, Mona L. ;
Fordyce, Colleen A. ;
McDermott, Kimberly M. ;
Tlsty, Thea D. .
BREAST CANCER RESEARCH, 2009, 11 (06)
[7]  
Elkak A, 2006, ANTICANCER RES, V26, P4901
[8]  
Elkak A E, 2005, J Carcinog, V4, P17, DOI 10.1186/1477-3163-4-17
[9]  
Han DF, 2005, CHINESE MED J-PEKING, V118, P1507
[10]  
Harvie M, 2003, Obes Rev, V4, P157, DOI 10.1046/j.1467-789X.2003.00108.x